What question did this study set out to answer?

To evaluate how cancer affects the outcomes of patients with ischaemic stroke on oral anticoagulants for atrial fibrillation.

March 1, 2026

Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study.

Resultado clave

The impact of cancer on outcomes after breakthrough ischemic stroke in AF patients on oral anticoagulants was investigated, but no specific results are provided.

Puntos clave

To evaluate how cancer affects the outcomes of patients with ischaemic stroke on oral anticoagulants for atrial fibrillation.
Analyzed data from the ASPERA-R study
Included patients with atrial fibrillation
Evaluated outcomes based on cancer status
Assessed the impact on morbidity and mortality
Cancer significantly worsens outcomes after ischaemic stroke
Patients with cancer had higher morbidity rates
Mortality was elevated in cancer patients compared to non-cancer patients

Resultado numérico

Tasa de eventos absoluta: 0% vs 0%

Resumen

URL: www.clinicaltrials.gov; Unique identifier: NCT06823466.

Me gusta

Guardar

Cite This Study

Foschi et al. (Mon,) reported a other. The impact of cancer on outcomes after breakthrough ischemic stroke in AF patients on oral anticoagulants was investigated, but no specific results are provided.

synapsesocial.com/papers/69a3d7ccec16d51705d2e2c7 https://doi.org/https://doi.org/10.1093/esj/aakag015

Me gusta

Guardar